Nariman F. Salakhutdinov

Dr. Nariman F. Salakhutdinov


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in Russian Chemical Reviews
Verified
Journal Article
Closed access
Valery N. CharushinValery N. Charushin
Valery N. Charushin
EVEgor Verbitskiy
Egor Verbitskiy
OCOleg N. Chupakhin
Oleg N. Chupakhin
DVD. V. Vorobyeva
D. V. Vorobyeva
PGPavel S. Gribanov
Pavel S. Gribanov
Alexey Yu. FedorovAlexey Yu. Fedorov
Alexey Yu. Fedorov
The chemistry of heterocyclic compounds has traditionally been and remains a bright area of chemical science in Russia. This is due to the fact that many heterocycles find the widest application. These compounds are the key structural fragments of most drugs, plant protection agents. Many natural compounds are also derivatives of heterocycles. At present, more than half of the hundreds of millions of known chemical compounds are heterocycles. This collective review is devoted to the achievements of Russian chemists in this field over the last 15–20 years. The review presents the achievements of leading heterocyclists representing both RAS institutes and university science. It is worth noting the wide scope of the review, both in terms of the geography of author teams, covering the whole of our large country, and in terms of the diversity of research areas. Practically all major types of heterocycles are represented in the review. The special attention is focused on the practical applications of heterocycles in the design of new drugs and biologically active compounds, high-energy molecules, materials for organic electronics and photovoltaics, new ligands for coordination chemistry, and many other rapidly developing areas. These practical advances would not be possible without the development of new fundamental transformations in heterocyclic chemistry. Bibliography — 2237 references.

29 April 2017 in Pure and Applied Chemistry
Verified
Journal Article
Open access
PDF file
NSNariman F. Salakhutdinov
Nariman F. Salakhutdinov
Konstantin VolchoKonstantin Volcho
Konstantin Volcho
Olga I. YarovayaOlga I. Yarovaya
Olga I. Yarovaya
Monoterpenes and their derivatives play an important role in the creation of new biologically active compounds including drugs. The review focuses on the data on various types of biological activity exhibited by monoterpenes and their derivatives, including analgesic, anti-inflammatory, anticonvulsant, antidepressant, anti-Alzheimer, anti-Parkinsonian, antiviral, and antibacterial (anti-tuberculosis) effects. Searching for novel potential drugs among monoterpene derivatives shows great promise for treating various pathologies. Special attention is paid to the effect of absolute configuration of monoterpenes and monoterpenoids on their activity.

1 May 2015 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
AZAlexandra Zakharenko
Alexandra Zakharenko
TKTatyana Khomenko
Tatyana Khomenko
SZSvetlana Zhukova
Svetlana Zhukova
OKOlga Koval
Olga Koval
OZOlga Zakharova
Olga Zakharova
Olga LavrikOlga Lavrik
Olga Lavrik

1 April 2021 in Russian Chemical Reviews
Verified
Journal Article
Closed access
Olga I. YarovayaOlga I. Yarovaya
Olga I. Yarovaya
NSNariman F. Salakhutdinov
Nariman F. Salakhutdinov
The revies focuses on low-molecular-weight plant metabolites (mono- and sesquiterpenes) exhibiting antiviral activity. Data on antiviral action of both essential oils and plant extracts and their components are provided. Structures of biologically active natural mono- and sesquiterpenoids as well as their derivatives showing a pronounced antiviral activity are presented. A special attention is given to the description of targets for antiviral therapy. The mechanisms of action of antiviral agents are considered. The bibliography includes 163 references.

11 August 2022 in Topics in Current Chemistry
Verified
Journal Article
Closed access
PDF file
Vladimir V. ChernyshovVladimir V. Chernyshov
Vladimir V. Chernyshov
IPIrina I. Popadyuk
Irina I. Popadyuk
Olga I. YarovayaOlga I. Yarovaya
Olga I. Yarovaya
NSNariman F. Salakhutdinov
Nariman F. Salakhutdinov

15 October 2019 in Molecules
Verified
Journal Article
Open access
PDF file
AFAleksandr Filimonov
Aleksandr Filimonov
ACArina Chepanova
Arina Chepanova
OLOlga Luzina
Olga Luzina
AZAlexandra Zakharenko
Alexandra Zakharenko
OZOlga Zakharova
Olga Zakharova
Olga LavrikOlga Lavrik
Olga Lavrik
Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is a promising therapeutic target in cancer therapy. Combination chemotherapy using Tdp1 inhibitors as a component can potentially improve therapeutic response to many chemotherapeutic regimes. A new set of usnic acid derivatives with hydrazonothiazole pharmacophore moieties were synthesized and evaluated as Tdp1 inhibitors. Most of these compounds were found to be potent inhibitors with IC50 values in the low nanomolar range. The activity of the compounds was verified by binding experiments and supported by molecular modeling. The ability of the most effective inhibitors, used at non-toxic concentrations, to sensitize tumors to the anticancer drug topotecan was also demonstrated. The order of administration of the inhibitor and topotecan on their synergistic effect was studied, suggesting that prior or simultaneous introduction of the inhibitor with topotecan is the most effective.